Literature DB >> 33486487

Interleukin-8 Levels in the Stratum Corneum as a Biomarker for Monitoring Therapeutic Effect in Atopic Dermatitis Patients.

Susumu Murata1, Sakae Kaneko2, Eishin Morita2.   

Abstract

INTRODUCTION: The stratum corneum contains several growth factors and cytokines that are synthesized in keratinocytes. We previously reported that the amount of interleukin-8 in the stratum corneum (scIL-8) is related to the severity of local skin inflammation in atopic dermatitis (AD). However, it is unknown whether scIL-8 levels reflect pharmacologic responses to a therapeutic intervention in AD patients. Therefore, in this study, we aimed to investigate whether the improvement of dermatitis in AD is correlated with scIL-8 levels before and after topical corticosteroid treatment.
METHODS: Stratum corneum samples were collected from 22 AD patients using the noninvasive tape-stripping method before treatment, 2 weeks after topical treatment, and 4-6 weeks after treatment.
RESULTS: scIL-8 levels on the forearm reduced significantly from 790 ± 348 pg/mg before treatment to 163 ± 68 pg/mg 2 weeks after treatment and 100 ± 37 pg/mg 4-6 weeks after corticosteroid treatment. scIL-8 levels on the abdomen also reduced significantly from 902 ± 391 to 142 ± 38 pg/mg at the end of study. The reduction in scIL-8 levels was associated with the improvement in local skin severity in AD. We also found that scIL-8 levels, along with blood biomarker levels (serum thymus and activation-regulated chemokine, lactate dehydrogenase, and %eosinophil), decreased significantly after the treatment.
CONCLUSION: The scIL-8 concentration decreases with improvements in skin symptoms in AD patients after topical corticosteroid treatment; thus, it may be a suitable biomarker for monitoring therapeutic effects in AD patients.
© 2021 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Atopic dermatitis; Biomarker; Interleukin-8; Stratum corneum; Tape-stripping method

Year:  2021        PMID: 33486487      PMCID: PMC8315684          DOI: 10.1159/000512965

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  37 in total

1.  English version of the concluding report published in 2001 by the Advisory Committee on Atopic Dermatitis Severity Classification Criteria of the Japanese Dermatological Association.

Authors:  Toshiyuki Aoki; Hikotaro Yoshida; Masutaka Furue; Hachiro Tagami; Fumio Kaneko; Fujio Ohtsuka; Kiyoshi Nishioka; Kiyoshi Toda; Masako Mizoguchi; Masamitsu Ichihashi; Hiroaki Ueki; Hideo Nakayama; Zenro Ikezawa; Masahiro Takigawa; Jiro Arata; Osamu Koro; Shoso Yamamoto; Yoichi Tanaka; Masahide Ishigaki; Tadashi Kusunoki; Kunihiko Yoshikawa
Journal:  J Dermatol       Date:  2011-07       Impact factor: 4.005

Review 2.  Atopic Dermatitis in Adults: A Diagnostic Challenge.

Authors:  J F Silvestre Salvador; D Romero-Pérez; B Encabo-Durán
Journal:  J Investig Allergol Clin Immunol       Date:  2017-01-10       Impact factor: 4.333

Review 3.  Emerging Treatment Options in Atopic Dermatitis: Systemic Therapies.

Authors:  Uffe Nygaard; Christian Vestergaard; Mette Deleuran
Journal:  Dermatology       Date:  2018-01-11       Impact factor: 5.366

4.  Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I.

Authors:  A Wollenberg; S Barbarot; T Bieber; S Christen-Zaech; M Deleuran; A Fink-Wagner; U Gieler; G Girolomoni; S Lau; A Muraro; M Czarnecka-Operacz; T Schäfer; P Schmid-Grendelmeier; D Simon; Z Szalai; J C Szepietowski; A Taïeb; A Torrelo; T Werfel; J Ring
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-05       Impact factor: 6.166

5.  Serum levels of CCL17/TARC in various skin diseases.

Authors:  Kunihiko Tamaki; Takashi Kakinuma; Hidehisa Saeki; Tatsuya Horikawa; Youko Kataoka; Takao Fujisawa; Shinichi Sato; Kazuhiko Takehara; Takeshi Nakahara; Shuji Fukagawa; Masutaka Furue
Journal:  J Dermatol       Date:  2006-04       Impact factor: 4.005

Review 6.  Burden of atopic dermatitis in Asia.

Authors:  Tsen-Fang Tsai; Murlidhar Rajagopalan; Chia-Yu Chu; Lonabel Encarnacion; Robert A Gerber; Paul Santos-Estrella; Lyndon John Q Llamado; Anna M Tallman
Journal:  J Dermatol       Date:  2019-08-22       Impact factor: 4.005

7.  Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin.

Authors:  M Sticherling; E Bornscheuer; J M Schröder; E Christophers
Journal:  J Invest Dermatol       Date:  1991-01       Impact factor: 8.551

8.  Natural moisturizing factor components in the stratum corneum as biomarkers of filaggrin genotype: evaluation of minimally invasive methods.

Authors:  S Kezic; A Kammeyer; F Calkoen; J W Fluhr; J D Bos
Journal:  Br J Dermatol       Date:  2009-11       Impact factor: 9.302

9.  Neutrophil-activating proteins in psoriasis.

Authors:  J M Schröder; H Gregory; J Young; E Christophers
Journal:  J Invest Dermatol       Date:  1992-02       Impact factor: 8.551

10.  Interleukin-8 content in the stratum corneum as an indicator of the severity of inflammation in the lesions of atopic dermatitis.

Authors:  Tseveendorj Amarbayasgalan; Hitoshi Takahashi; Itaru Dekio; Eishin Morita
Journal:  Int Arch Allergy Immunol       Date:  2012-09-01       Impact factor: 2.749

View more
  2 in total

1.  Distribution of Cannabinoid Receptors in Keratinocytes of Healthy Dogs and Dogs With Atopic Dermatitis.

Authors:  Roberto Chiocchetti; Margherita De Silva; Francesca Aspidi; Rodrigo Zamith Cunha; Francesca Gobbo; Claudio Tagliavia; Giuseppe Sarli; Maria Morini
Journal:  Front Vet Sci       Date:  2022-07-08

Review 2.  A Systematic Review of Keratinocyte Secretions: A Regenerative Perspective.

Authors:  Ahmed T El-Serafi; Ibrahim El-Serafi; Ingrid Steinvall; Folke Sjöberg; Moustafa Elmasry
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.